ONCOPHAGE

The mark consists of the word "oncophage" in lower case letters with two curved lines and a circle appearing above the letters "onco".

Mark For: ONCOPHAGE® trademark registration is intended to cover the categories of pharmaceutical and biopharmaceutical agents, namely, vaccines and immunotherapeutics, for the prevention and treatment of human diseases in the fields of autoimmunity, oncology, and infectious diseases. [all]

>Color is not claimed as a feature of the mark. The mark consists of the word "oncophage" in lower case letters with two curved lines and a circle appearing above the letters "onco".

Status

2020-12-15 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	78608250
Registration Number	3644943
Mark Literal Elements	ONCOPHAGE
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2009-05-19
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	Christina M. Licursi
Law Office Assigned	L50
Employee Name	YONTEF, DAVID ERIC

Timeline

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and biopharmaceutical agents, namely, vaccines and immunotherapeutics, for the prevention and treatment of human diseases in the fields of autoimmunity, oncology, and infectious diseases. FIRST USE: 20070430. FIRST USE IN COMMERCE: 20070430(CANCELLED)
IC 016. US 002 005 022 023 029 037 038 050. G & S: Printed matter, namely, monographs and selling aids in the nature of brochures, manuals, pamphlets, leaflets and charts in the fields of medicines, medical therapies and patient education. FIRST USE: 20090416. FIRST USE IN COMMERCE: 20090416(CANCELLED)
IC 044. US 100 101. G & S: Medical, pharmaceutical and health care services, namely, providing information and advice to patients and health care professionals regarding the use of pharmaceutical agents and biopharmaceutical agents, including vaccines and immunotherapeutics, for the prevention or treatment of human diseases. FIRST USE: 20050930. FIRST USE IN COMMERCE: 20050930